is exendin-4 in tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity 🦎 Did you know this

Martha Viera, MD References National Library of Medicine, 2024, Glucagon-Like Peptide-1 Receptor Agonists Sofwave, Lost Weight, Gained Loose Skin or Muscle Loss

It has documented thousands of cases where approved drugs later proved far more dangerous than initially disclosed

Patients with diabetes taking insulin or sulphonylureas alongside GLP-1 agonists face increased risk of hypoglycaemia-related dizziness

You may qualify if you are an adult seeking medical weight-management support and meet certain health criteria

Updated July 2026

It is acceptable to step back down to a lower dose if side effects become intolerable